Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
5.50
-0.18 (-3.17%)
At close: Apr 24, 2025, 4:00 PM
5.49
-0.01 (-0.18%)
Pre-market: Apr 25, 2025, 4:00 AM EDT
Precision BioSciences Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Precision BioSciences stock have an average target of 37.67, with a low estimate of 19 and a high estimate of 60. The average target predicts an increase of 584.91% from the current stock price of 5.50.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Precision BioSciences stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +990.91% | Mar 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +990.91% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +990.91% | Feb 19, 2025 |
| BMO Capital | BMO Capital | Hold → Buy Upgrades $34 | Hold → Buy | Upgrades | $34 | +518.18% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +990.91% | Jan 10, 2025 |
Financial Forecast
Revenue This Year
22.41M
from 68.70M
Decreased by -67.38%
Revenue Next Year
29.17M
from 22.41M
Increased by 30.20%
EPS This Year
-5.48
from 1.04
EPS Next Year
-3.86
from -5.48
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 47.9M | 69.8M | 79.5M | ||
| Avg | 22.4M | 29.2M | 32.0M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -30.3% | 211.6% | 172.5% | ||
| Avg | -67.4% | 30.2% | 9.6% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -1.10 | 0.06 | -4.59 | |
| Avg | -5.48 | -3.86 | -4.46 | |
| Low | -9.60 | -6.76 | -4.28 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.